Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers.

Akimoto M, Kozako T, Sawada T, Matsushita K, Ozaki A, Hamada H, Kawada H, Yoshimitsu M, Tokunaga M, Haraguchi K, Uozumi K, Arima N, Tei C.

J Med Virol. 2007 Jul;79(7):977-86.

PMID:
17516523
2.

Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I.

Birmann BM, Mueller NE, Okayama A, Hsieh CC, Tsubouchi H, Harn D, Stuver SO.

J Med Virol. 2006 Jun;78(6):847-52.

PMID:
16628590
3.

Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers.

Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE.

J Infect Dis. 2004 Nov 1;190(9):1605-9. Epub 2004 Sep 21.

PMID:
15478065
4.

Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults.

Birmann BM, Mueller N, Okayama A, Hsieh CC, Tachibana N, Tsubouchi H, Lennette ET, Harn D, Stuver S.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1385-91.

5.

Potential role of immune system activation-associated production of neopterin derivatives in humans.

Hoffmann G, Wirleitner B, Fuchs D.

Inflamm Res. 2003 Aug;52(8):313-21. Review.

PMID:
14504669
6.
7.

Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.

Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B.

Virology. 2003 Mar 30;308(1):1-12. Review.

9.

Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.

Mortreux F, Gabet AS, Wattel E.

Leukemia. 2003 Jan;17(1):26-38. Review.

PMID:
12529656
10.

A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.

Arisaw K, Katamine S, Kamihira S, Kurokawa K, Sawada T, Soda M, Doi H, Saito H, Shirahama S.

Cancer Causes Control. 2002 Sep;13(7):657-63.

PMID:
12296513
11.

SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation.

Nagy N, Maeda A, Bandobashi K, Kis LL, Nishikawa J, Trivedi P, Faggioni A, Klein G, Klein E.

Int J Cancer. 2002 Aug 1;100(4):433-40.

12.

Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W.

J Clin Endocrinol Metab. 2001 Mar;86(3):1154-9.

PMID:
11238501
14.

Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.

Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1705-9.

PMID:
11080814
15.

Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.

Araki K, Harada K, Nakamoto K, Shiroma M, Miyakuni T.

Clin Exp Immunol. 2000 Feb;119(2):259-63.

16.
17.
18.

Human T-cell lymphotropic viruses.

[No authors listed]

IARC Monogr Eval Carcinog Risks Hum. 1996;67:261-390. Review. No abstract available.

PMID:
9103967
19.

Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.

Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S.

Am J Trop Med Hyg. 1997 Jan;56(1):71-5.

PMID:
9063365
20.

Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Lucey DR, Clerici M, Shearer GM.

Clin Microbiol Rev. 1996 Oct;9(4):532-62. Review.

Supplemental Content

Support Center